A detailed history of Creative Planning transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Creative Planning holds 16,498 shares of SNDX stock, worth $215,793. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,498
Previous 18,428 10.47%
Holding current value
$215,793
Previous $378,000 16.14%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$17.93 - $24.81 $34,604 - $47,883
-1,930 Reduced 10.47%
16,498 $317,000
Q2 2024

Aug 15, 2024

BUY
$18.82 - $23.79 $74,564 - $94,255
3,962 Added 27.39%
18,428 $378,000
Q1 2024

May 10, 2024

BUY
$19.71 - $24.57 $61,830 - $77,076
3,137 Added 27.69%
14,466 $344,000
Q4 2023

Feb 14, 2024

BUY
$11.39 - $21.67 $129,037 - $245,499
11,329 New
11,329 $244,000

Others Institutions Holding SNDX

About Syndax Pharmaceuticals Inc


  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $740M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.